We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Judge Adjourns Injunction Hearing In Neurontin Case

Law360 (September 26, 2004, 12:00 AM EDT) -- The judge presiding over Pfizer’s lawsuit against generics maker Alpharma Inc. over patent rights to the epilepsy drug Neurontin has adjourned a preliminary-injunction hearing until Monday morning.

The companies are arguing the injunction before Judge John C. Lifland of the U.S. District Court for the District of New Jersey.

"The court indicated that it would be preferable to maintain the status quo, i.e., no generics, though the judge said he would not further any injunctive relief at this time," CIBC World Markets analyst Elliot Wilbur wrote...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.